Actinium Pharmaceuticals presented long-term safety data for Actimab-A combined with CLAG-M chemotherapy in relapsed or refractory acute myeloid leukemia (AML) patients. The follow-up showed manageable blood count recovery and no significant delayed kidney or liver toxicities, complementing earlier efficacy results that showed promising survival rates even in difficult cases like TP53 mutations and venetoclax failure. These findings support Actimab-A's potential as a mutation-agnostic treatment backbone for AML, with plans for further clinical evaluation to improve outcomes and expand options for resistant AML patients.
Actinium Pharmaceuticals' long-term safety data for Actimab-A in AML patients provides context for readers. For those following the health sector, here is Pluang's market snapshot as of Nov 04, 2026 20:41 WIB: out of 150 priced US health stocks, 127 rose and 19 fell today. Notable movers include Novo Nordisk A/S (NVO) at USD 42.40 with a 5.50% increase and 90% buy order activity, Amgen, Inc. (AMGN) at USD 486.50 up 5.47% with 68% buy orders, and Heron Therapeutics Inc (HRTX) at USD 0.30 gaining 5.37% with 66% buy orders.
Kelly Technology + Motion Recruitment, a division of Kelly Services, has been recognized as a Leader on Everest Group's 2026 U.S. IT Contingent Talent and Strategic Solutions PEAK Matrix® for its expertise in specialized IT staffing, consulting, and ...
Sutro Biopharma, a clinical-stage oncology company specializing in antibody drug conjugates (ADCs), announced its participation in several investor conferences in November and December 2026, including events hosted by Stifel, Truist Securities, UBS, ...
etoro has agreed to acquire LB Finanzas, a leading Argentine all-in-one financial app, to strengthen its presence in Latin America's fast-growing fintech market. LB Finanzas offers integrated investing and payment solutions, catering to Argentine ret...
JD.com announced it will publish its unaudited financial results for the third quarter of 2026 on November 17, before the U.S. market opens. The company's management will hold a conference call the same day to discuss the results, providing investors...
KE Holdings Inc., a major online and offline housing platform in China, will announce its unaudited financial results for the third quarter of 2026 on November 16 before the U.S. market opens. The company will host an earnings conference call at 7:00...
